Showing results (201-210 of 207) with videos related to
Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
Cornea|December 8, 2011
Role of the TCF4 gene intronic variant in normal variation of corneal endotheliumDavid A Mackey, Nicole M Warrington, Alex W Hewitt, et al.JBMR Plus|July 14, 2021
Skeletal responses to romosozumab after 12 months of denosumabMichael R McClung, Michael A Bolognese, Jacques P Brown, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implicationsM A Kling, D L Gardner, A E Calogero, et al.The Journal of Biological Chemistry|July 26, 2003
Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAILMamta Chawla-Sarkar, Joseph A Bauer, Joseph A Lupica, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 15, 2022
Romosozumab and antiresorptive treatment: the importance of treatment sequenceFelicia Cosman, David L Kendler, Bente L Langdahl, et al.Ophthalmic Genetics|January 11, 2013
Raine eye health study: design, methodology and baseline prevalence of ophthalmic disease in a birth-cohort study of young adultsSeyhan Yazar, Hannah Forward, Charlotte M McKnight, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2021
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trialJacques P Brown, Klaus Engelke, Tony M Keaveny, et al.Pageof 21